← Back to Search

Probiotic Blend for Teen Stress (TEEN Trial)

Phase 2
Waitlist Available
Led By David Crowley, M.D
Research Sponsored by Lallemand Health Solutions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 63 days

Summary

This trial tests whether a mix of good bacteria (probiotics) can reduce stress in teenagers who feel moderately stressed. Participants will take the probiotics for a few months and have regular check-ins. The idea is that these good bacteria might help balance the gut, which could make the participants feel less stressed. Probiotics have been reported to exert beneficial effects along the gut-brain axis, reducing symptoms of stress.

Who is the study for?
This trial is for teens aged 13-17 with moderate stress, not pregnant or planning to become so, and willing to use birth control if sexually active. They must be attending school, speak English fluently, agree to avoid certain products like probiotic supplements during the study, and maintain their lifestyle habits. Teens with mental health disorders or significant medical conditions are excluded.
What is being tested?
The study aims to see if a special blend of probiotics can help reduce stress in moderately stressed teenagers compared to a placebo. Participants will either receive the probiotic blend or a placebo and their stress levels will be monitored to determine any differences between the two groups.
What are the potential side effects?
While specific side effects aren't listed for this trial, common side effects from taking probiotics may include digestive discomfort such as gas or bloating. Since it's a natural supplement being tested against a placebo, severe side effects are unlikely.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~63 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 63 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in stress at day 56 from baseline
Secondary study objectives
Change in daytime sleepiness from baseline
Change in gastrointestinal symptoms from baseline
Change in mood from baseline
+8 more
Other study objectives
Adverse events
Clinically relevant vital signs - blood pressure
Clinically relevant vital signs - heart rate

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ProbioticExperimental Treatment1 Intervention
Participants will be randomized to receive the probiotic blend for 56 days.
Group II: PlaceboPlacebo Group1 Intervention
Participants will be randomized to receive the placebo for 56 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Probiotic Blend
2023
Completed Phase 2
~30

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for stress include probiotics, which influence the gut-brain axis. Probiotics can modulate the gut microbiota, leading to the production of neurotransmitters and other signaling molecules that affect brain function and stress response. This is particularly relevant for stress patients as it offers a potential non-pharmacological approach to managing stress by improving gut health, which in turn can enhance mental well-being and reduce stress levels.
Evaluation of an Immunomodulatory Probiotic Intervention for Veterans With Co-occurring Mild Traumatic Brain Injury and Posttraumatic Stress Disorder: A Pilot Study.

Find a Location

Who is running the clinical trial?

KGK Science Inc.Industry Sponsor
78 Previous Clinical Trials
6,130 Total Patients Enrolled
Lallemand Health SolutionsLead Sponsor
41 Previous Clinical Trials
3,946 Total Patients Enrolled
Erin Lewis, Ph.D.Study DirectorKGK Science Inc.

Media Library

Placebo Clinical Trial Eligibility Overview. Trial Name: NCT05766306 — Phase 2
Stress Research Study Groups: Probiotic, Placebo
Stress Clinical Trial 2023: Placebo Highlights & Side Effects. Trial Name: NCT05766306 — Phase 2
Placebo 2023 Treatment Timeline for Medical Study. Trial Name: NCT05766306 — Phase 2
~12 spots leftby Oct 2025